Showing results (371-380 of 399) with videos related to

Sort By:
Pageof 40
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2023
Survival update of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma in the OpACIN and OpACIN-neo trialsJ M Versluis, A M Menzies, K Sikorska, et al.
The New Phytologist|February 25, 2024
Segmental duplications drive the evolution of accessory regions in a major crop pathogenAnouk C van Westerhoven, Carolina Aguilera-Galvez, Giuliana Nakasato-Tagami, et al.
European Journal of Cancer (Oxford, England : 1990)|September 26, 2022
Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort studyLeonie Müller-Jensen, Sarah Zierold, Judith M Versluis, et al.
The Journal of Experimental Medicine|March 15, 2023
IFN-γ signature enables selection of neoadjuvant treatment in patients with stage III melanomaIrene L M Reijers, Disha Rao, Judith M Versluis, et al.
Data in Brief|November 25, 2022
Dataset of a retrospective multicenter cohort study on characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitisLeonie Müller-Jensen, Sarah Zierold, Judith M Versluis, et al.
The Science of the Total Environment|May 19, 2022
SARS-CoV-2 variant trends in Ireland: Wastewater-based epidemiology and clinical surveillanceLiam J Reynolds, Gabriel Gonzalez, Laura Sala-Comorera, et al.
Water Research|August 7, 2013
Multi-laboratory evaluations of the performance of Catellicoccus marimammalium PCR assays developed to target gull fecal sourcesChristopher D Sinigalliano, Jared S Ervin, Laurie C Van De Werfhorst, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 25, 2018
Functional Ex Vivo Assay Reveals Homologous Recombination Deficiency in Breast Cancer Beyond BRCA Gene DefectsTitia G Meijer, Nicole S Verkaik, Anieta M Sieuwerts, et al.
European Journal of Cancer (Oxford, England : 1990)|November 27, 2024
Impact of personalized response-directed surgery and adjuvant therapy on survival after neoadjuvant immunotherapy in stage III melanoma: Comparison of 3-year data from PRADO and OpACIN-neoIrene L M Reijers, Alexander M Menzies, Marta Lopez-Yurda, et al.
Nature Medicine|September 22, 2022
Diet-driven microbial ecology underpins associations between cancer immunotherapy outcomes and the gut microbiomeRebecca C Simpson, Erin R Shanahan, Marcel Batten, et al.
Pageof 40